Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 40: 56-61, 1994;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bock, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bock, J. L.

Clinical Chemistry, Vol 40, 56-61, Copyright © 1994 by American Association for Clinical Chemistry

Metabolic profiling of amniotic fluid by proton nuclear magnetic resonance spectroscopy: correlation with fetal maturation and other clinical variables

JL Bock
Department of Pathology, State University of New York at Stony Brook 11794-7300.

Proton NMR spectroscopy at 600 MHz was performed on 70 specimens of human amniotic fluid, representing pregnancies at different stages of maturation and with different fetomaternal complications. Spectra with good signal-to-noise characteristics were obtained in 3.5 min of acquisition time, directly on untreated fluid, with presaturation to suppress the intense water resonance. Metabolites that generally gave rise to well-resolved resonances included lactate, glucose, creatinine, choline derivatives, citrate, acetate, alanine, glycine, glutamate, succinate, and others. For three of these metabolites--creatinine, glucose, and lactate--the peak intensities correlated well with results of conventional chemical analysis. The NMR spectra of third-trimester specimens were readily distinguishable from those of second-trimester specimens, and several peak intensities correlated with fetal maturation during the third trimester. Significant correlations with maternal preeclampsia and fetal open spina bifida were also observed.


The following articles in journals at HighWire Press have cited this article:


Home page
 Mol Hum ReprodHome page
L. Botros, D. Sakkas, and E. Seli
Metabolomics and its application for non-invasive embryo assessment in IVF
Mol. Hum. Reprod., December 1, 2008; 14(12): 679 - 690.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
E. R. Ashwood
Standards of laboratory practice: evaluation of fetal lung maturity
Clin. Chem., January 1, 1997; 43(1): 211 - 214.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American Association for Clinical Chemistry.